We're working together to find and fight Cancer

RhoDx is dedicated to unleashing the power of liquid biopsy to fight cancer. Our cell free DNA/RNA enrichment technologies deliver transformative improvements in performance and efficiency to ensure liquid biopsy will be an accessible and effective weapon against cancer.

RhoDx blends decades of experience in biotech and pharma with an expert understanding of the entrepreneurial journey. We came together because we believe the next leap forward in the lives of cancer patients will stem from earlier, deeper diagnoses and individual mechanistic disease characterization.

RhoDx blends decades of experience in biotech and pharma with an expert understanding of the entrepreneurial journey. We came together because we believe the next leap forward in the lives of cancer patients will stem from earlier, deeper diagnoses and individual mechanistic disease characterization.

Steve Wallace
CEO

Steve Wallace has 25 years of molecular diagnostics experience with both global corporations and early-stage ventures. Dedicated to fighting cancer, he led commercial development of the CancerSEEK assay at PapGene (later Thrive Earlier Detection) and their $110M funding transaction. Mr. Wallace holds a BA in Molecular Biology from the University of Colorado and an MBA from Harvard Business School.

Charlie Rodi
Founder and CSO

Dr. Rodi has over 30 years of leadership in both Big Pharma and Biotech start-ups. He has brought products to the marketplace for genetic analysis and molecular diagnostics and has led teams involved in drug screeing, cancer diagnostics, and antineoplastic therapeutics. Dr. Rodi received a Ph.D. from the University of Minnesota and performed post-doctoral studies at the NIH.

RhoDx's Heredia Headshot

Carlos Heredia
CFO, General Counsel and Corporate Secretary

Carlos Heredia has advised technology growth companies for over 25 years, with significant experience forming, funding, guiding and growing companies across various stages of development. Mr. Heredia is a graduate of Stanford Law School and the Stanford Graduate School of Business.